Search

everythinglearnresearchcommunity

for

Search:↓

Estrogens and progesterone are key in regulating melasma pigmentation.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

A PET-CT scan successfully located a hard-to-find Leydig cell tumor in a woman with hormonal symptoms.

Spironolactone may help treat excessive hair growth in girls, but more research is needed.

The document does not determine if adults with aphallia are fertile.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

The diagnosis of polycystic ovary syndrome (PCOS) requires a detailed patient history, ultrasound scanning, hormone level checks, and assessments of ovulation, obesity, and insulin resistance. It's a variable condition that needs individualized management and is a significant risk factor for type 2 diabetes.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Higher androgen levels during puberty are linked to shorter adult height in boys with Silver-Russell syndrome.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

Hair loss in postmenopausal woman caused by ovarian issue.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Taking 100 mg of DHEA daily for 16 weeks did not change metabolic and reproductive health significantly but increased certain ovarian markers with minimal side effects.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

Cetuximab can cause unusual hair growth and hair loss.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

A toddler with a rare adrenal gland tumor causing male-like physical changes was successfully treated with surgery.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.